You are required to be logged in to access the full website
Click here if you have forgotten your username or password
25 June 2026 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, announced on Thursday that the US Food and Drug Administration (FDA) has approved Keytruda (pembrolizumab) and Keytruda Qlex (pembrolizuma...
25 June 2026 - Biotechnology company Ionis Pharmaceuticals Inc (Nasdaq:IONS) said on Thursday that it has entered into a licensing agreement granting Recordati exclusive rights to develop and commercialise zilganersen for Alexander disease (AxD) in a...
25 June 2026 - Swedish pharmaceutical company Dicot Pharma AB (Nasdaq First North:DICOT) said on Thursday that it has received clearance from the US Food and Drug Administration (FDA) to initiate Part I of its Phase 2b study for LIB-01, an investigat...
25 June 2026 - US pharmaceutical company CeleCor Therapeutics said on Wednesday that it has submitted the final section of its New Drug Application (NDA) for the company's investigational heart-attack drug, zalunfiban (Disaggpro), to the US Food...
25 June 2026 - Biosidus, an Argentina-based biotechnology company, announced on Wednesday the signing of a licensing and supply agreement with Mubadala Bio, the life sciences platform of Mubadala Investment Company, to introduce a portfolio of biolog...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe